Ask AI
Bill114th CongressFiled Feb 12, 2015Health
S. 480

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary reported to senate with amendment(s) (Apr 27, 2016)

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

(Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain existing state controlled substance monitoring programs;
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees;
  • require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request;
  • require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and
  • expand the program to include any commonwealth or territory of the United States.

The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.

What just happenedApr 27, 2016

Placed on Senate Legislative Calendar under General Orders. Calendar No. 440.

Who’s behind it

Sen. Shaheen, Jeanne [D-NH](D-NH)Sponsor
12 cosponsors9 D3 R
Read on Congress.gov
12cosponsors1committees6actions2related bills11subjects
  1. Apr 27, 2016Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 440.

  2. Apr 27, 2016Committee

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  3. Apr 27, 2016Committee14000

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  4. Mar 16, 2016Committee

    Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Health, Education, Labor, and Pensions Committee
  5. Feb 12, 2015IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  6. Feb 12, 2015IntroReferral10000

    Introduced in Senate

Reported to Senate with amendment(s)Apr 27, 20161

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

(Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain existing state controlled substance monitoring programs;
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees;
  • require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request;
  • require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and
  • expand the program to include any commonwealth or territory of the United States.

The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.

Introduced in SenateFeb 12, 2015

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain and operate existing state controlled substance monitoring programs,
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees,
  • require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and
  • expand the program to include any commonwealth or territory of the United States.

Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016 — Informed